Skip to main content
NIH funding notice RFA-AI-18-015

Advancing HIV Therapeutic Vaccine Science (U01 Clinical Trial Required)

Closed on September 27, 2018.

Posted
April 25, 2018
Close date
September 27, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,509,907 in first-year total cost, median $1,509,907.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 CB-A (M1)]1

Most frequent institutions

  1. BETH ISRAEL DEACONESS MEDICAL CENTER1
Competing awards under RFA-AI-18-015 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Ad26 Based Therapeutic Vaccines for HIV1U01AI145801-01BAROUCH, DAN H.JUELG, BORIS DOMINIKBETH ISRAEL DEACONESS MEDICAL CENTER, MA$1,509,907ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.